603122.SHG Cowealth Medical China Co.Ltd.
- Market cap
- CNY 4.41B
- P/E
- -
- P/B
- 4.15x
- ROE
- -0.7%
- Dividend yield
- 1.19%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 603122.SHG undervalued?
Graham numberThe Graham number of Cowealth Medical China Co.Ltd. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cowealth Medical China Co.Ltd. fundamental analysis
No fundamental analysis for Cowealth Medical China Co.Ltd. yet.
Cowealth Medical China Co.Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cowealth Medical China Co.Ltd.
Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers centralized procurement services for in-vitro diagnostic reagents and consumables; platform for decision-making and analysis, commercialization of achievements in medical science and technology; a multi-channel coaxial time audio video imaging platform; and an AI-assisted system for clinical diagnosis. The company was founded in 1997 and is based in Shanghai, China.
Full company profileCowealth Medical China Co.Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cowealth Medical China Co.Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1.05B | 1.09B | 1.19B | 1.28B | 1.09B | 939M | 678M | 681M |
| Gross Profit | 231M | 225M | 250M | 258M | 226M | 184M | 100M | 127M |
| Operating Income | 116M | 116M | 113M | 112M | 67.6M | 36.1M | -23.5M | 10.8M |
| EBITDA | 118M | 118M | 129M | 130M | 83.1M | 53.2M | -27.5M | -5.80M |
| Net Income | 67.1M | 72.6M | 80.2M | 82.7M | 47.2M | 27.6M | -33.6M | -7.52M |
| EPS | 0.22 | 0.24 | 0.27 | 0.21 | 0.12 | 0.07 | -0.08 | -0.02 |
| Balance Sheet | ||||||||
| Total Assets | 1.13B | 1.11B | 1.12B | 1.56B | 1.46B | 1.49B | 1.43B | 1.44B |
| Total Liabilities | 341M | 395M | 325M | 380M | 292M | 319M | 369M | 397M |
| Shareholders' Equity | 789M | 717M | 796M | 1.18B | 1.17B | 1.17B | 1.06B | 1.04B |
| Cash & Short-term Investments | 56.2M | 247M | 147M | 327M | 198M | 261M | 106M | 140M |
| Cash Flow | ||||||||
| Operating Cash Flow | -37.9M | 74.2M | 7.01M | -30.4M | 11.3M | 133M | 17.7M | - |
| Capital Expenditure | 27.8M | 8.11M | 22.1M | 25.9M | 68.0M | 31.8M | 14.2M | 686K |
| Free Cash Flow | -65.7M | 66.0M | -15.1M | -56.3M | -56.7M | 101M | 3.47M | 25.2M |
| Ratios | ||||||||
| ROE | 8.5% | 10.1% | 10.1% | 7.0% | 4.0% | 2.4% | -3.2% | -0.7% |
| ROA | 5.9% | 6.5% | 7.2% | 5.3% | 3.2% | 1.8% | -2.4% | -0.5% |
| Net Profit Margin | 6.4% | 6.7% | 6.7% | 6.5% | 4.3% | 2.9% | -5.0% | -1.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Cowealth Medical China Co.Ltd. dividends
- Dividend yield
- 1.19%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jul 14, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 52.7M | 0.13 | - |
| 2024 | CNY 26.9M | 0.07 | 97.8% |
| 2023 | CNY 65.3M | 0.16 | 138.3% |
| 2022 | CNY 74.5M | 0.19 | 90.1% |
| 2021 | CNY 79.7M | 0.27 | 99.3% |
| 2020 | CNY 46.2M | 0.15 | 63.7% |
| 2019 | CNY 41.1M | 0.14 | 61.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Cowealth Medical China Co.Ltd.
- Insiders 54.20%
- Institutions 1.09%
- Public & others 44.71%
- Shares outstanding 398M
- Free float 191M
Cowealth Medical China Co.Ltd. company profile
- Company name
- Cowealth Medical China Co.Ltd.
- Ticker
- 603122.SHG
- ISIN
- CNE100005R39
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 161
- Fiscal year end
- December
- Address
- Guangqi Building, Shanghai, China, 200233
- Phone
- 86 40 0678 8855
- Website
- ch.cowealth.com
About Cowealth Medical China Co.Ltd.
Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers centralized procurement services for in-vitro diagnostic reagents and consumables; platform for decision-making and analysis, commercialization of achievements in medical science and technology; a multi-channel coaxial time audio video imaging platform; and an AI-assisted system for clinical diagnosis. The company was founded in 1997 and is based in Shanghai, China.
Cowealth Medical China Co.Ltd. management
7- Ms. Qiongzhi WangGM, CFO & Director · born 1957
- Mr. Guankai ZengDeputy GM & Director · born 1977
- Ms. Ying ZhuSecretary · born 1976
- Ms. Ye ChenDeputy General Manager · born 1978
- Mr. Fenghua WangDeputy General Manager · born 1962
- Mr. Shengrong YangDeputy General Manager · born 1962
- Heng Zheng GaoAccounting Supervisor